BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kermani TA, Crowson CS, Achenbach SJ, Luthra HS. Idiopathic retroperitoneal fibrosis: a retrospective review of clinical presentation, treatment, and outcomes. Mayo Clin Proc. 2011;86:297-303. [PMID: 21454732 DOI: 10.4065/mcp.2010.0663] [Cited by in Crossref: 75] [Cited by in F6Publishing: 60] [Article Influence: 6.8] [Reference Citation Analysis]
Number Citing Articles
1 Mukai S, Sakamoto N, Kakinoki H, Shibuya T, Moriya R, Nishihara K, Noguchi M, Shin T, Fujimoto N, Igawa T, Ishii T, Haga N, Enokida H, Eto M, Kamba T, Sakai H, Saito S, Terada N, Kamoto T. Serum IgG4 Concentration Is a Potential Predictive Biomarker in Glucocorticoid Treatment for Idiopathic Retroperitoneal Fibrosis. J Clin Med 2022;11:3538. [PMID: 35743608 DOI: 10.3390/jcm11123538] [Reference Citation Analysis]
2 Patra S, Padhi S, Padhan P, Kar M, Nayak P, Samal SC. Ergotamine Induced Retroperitoneal Fibrosis. Mediterr J Rheumatol 2021;32:168-73. [PMID: 34447915 DOI: 10.31138/mjr.32.2.168] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Mizushima I, Kawano M. Renal Involvement in Retroperitoneal Fibrosis: Prevalence, Impact and Management Challenges. Int J Nephrol Renovasc Dis 2021;14:279-89. [PMID: 34349543 DOI: 10.2147/IJNRD.S239160] [Reference Citation Analysis]
4 Uddin M, Varley R, Napier-hemy R. Our experience in laparoscopic ureterolysis and omental wrapping as a definitive surgical management of ureteric obstruction related to retroperitoneal fibrosis. Journal of Clinical Urology. [DOI: 10.1177/20514158211022215] [Reference Citation Analysis]
5 Ali SK, Du K, Orare K. Idiopathic Retroperitoneal Fibrosis: An East African Diagnostic Challenge. Cureus 2021;13:e15683. [PMID: 34277272 DOI: 10.7759/cureus.15683] [Reference Citation Analysis]
6 Altshuler E. Atypical Presentation of Idiopathic Retroperitoneal Fibrosis Effectively Treated With Colchicine After Lymphoma Misdiagnosis. Cureus 2021;13:e14756. [PMID: 34094726 DOI: 10.7759/cureus.14756] [Reference Citation Analysis]
7 Capecchi R, Giannese D, Moriconi D, Bonadio AG, Pratesi F, Croia C, Egidi MF, Puxeddu I, Tavoni AG, Migliorini P. Renal Involvement in IgG4-Related Disease: From Sunlight to Twilight. Front Med (Lausanne) 2021;8:635706. [PMID: 33869249 DOI: 10.3389/fmed.2021.635706] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Wallwork R, Perugino CA, Fu X, Harkness T, Zhang Y, Choi HK, Stone JH, Wallace ZS. The Association of Smoking with IgG4-Related Disease: A Case-Control Study. Rheumatology (Oxford) 2021:keab172. [PMID: 33751033 DOI: 10.1093/rheumatology/keab172] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Fenaroli P, Maritati F, Vaglio A. Into Clinical Practice: Diagnosis and Therapy of Retroperitoneal Fibrosis. Curr Rheumatol Rep 2021;23:18. [PMID: 33569638 DOI: 10.1007/s11926-020-00966-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Choi SJ, Oh JS, Hong S, Lee C, Yoo B, Hong B, Kim Y. Treatment Response to Idiopathic Retroperitoneal Fibrosis-associated Hydronephrosis With a Focus on IgG4/IgG3 Serum Concentration Ratio. J Rheum Dis 2021;28:38-44. [DOI: 10.4078/jrd.2021.28.1.38] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 R D, Td B, G EW, N G, Jc M, P M, Cd P, Fwk T, P TJA; RaDaR rare disease group (RDG). An International Patient Centred Study Of Retroperitoneal Fibrosis. QJM 2020:hcaa327. [PMID: 33377941 DOI: 10.1093/qjmed/hcaa327] [Reference Citation Analysis]
12 Sheth R, Malik D. Bilateral Hydronephrosis From Retroperitoneal Fibrosis. Cureus 2020;12:e12147. [PMID: 33489559 DOI: 10.7759/cureus.12147] [Reference Citation Analysis]
13 Raglianti V, Rossi GM, Vaglio A. Idiopathic retroperitoneal fibrosis: an update for nephrologists. Nephrol Dial Transplant 2020:gfaa083. [PMID: 33005943 DOI: 10.1093/ndt/gfaa083] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
14 Roussel E, Callemeyn J, Van Moerkercke W. Standardized approach to idiopathic retroperitoneal fibrosis: a comprehensive review of the literature. Acta Clin Belg 2020;75:239-44. [PMID: 31035909 DOI: 10.1080/17843286.2019.1609152] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 Le Joncour A, Saadoun D, Cacoub P. La fibrose rétropéritonéale idiopathique. Rev Med Interne 2020;41:822-8. [PMID: 32727694 DOI: 10.1016/j.revmed.2020.06.013] [Reference Citation Analysis]
16 Moriconi D, Giannese D, Capecchi R, Cupisti A, Barsotti S, Morganti R, Orsitto E, Gaetano Tavoni A, Francesca Egidi M. Risk factors for relapse and long-term outcome of idiopathic retroperitoneal fibrosis. Clin Exp Nephrol 2019;23:1147-53. [PMID: 31230189 DOI: 10.1007/s10157-019-01759-w] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
17 Koike Y, Matsui S, Takase K, Tannai H. CT-Guided Percutaneous Needle Biopsy in Patients with Suspected Retroperitoneal Fibrosis: A Retrospective Cohort Study. Cardiovasc Intervent Radiol 2019;42:1434-40. [PMID: 31292673 DOI: 10.1007/s00270-019-02266-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
18 Raffiotta F, da Silva Escoli R, Quaglini S, Rognoni C, Sacchi L, Binda V, Messa P, Moroni G. Idiopathic Retroperitoneal Fibrosis: Long-term Risk and Predictors of Relapse. Am J Kidney Dis 2019;74:742-50. [PMID: 31204195 DOI: 10.1053/j.ajkd.2019.04.020] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
19 Choi YK, Yang JH, Ahn SY, Ko GJ, Oh SW, Kim MG, Cho WY, Jo SK. Retroperitoneal fibrosis in the era of immunoglobulin G4-related disease. Kidney Res Clin Pract 2019;38:42-8. [PMID: 30754935 DOI: 10.23876/j.krcp.18.0052] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
20 Nguyen TV, Bader NM, Sidhu H, Cadacio C, Mendoza SM, Pham PTT, Pham PCT. Acute Kidney Failure in a Young African American Male. Case Rep Nephrol 2019;2019:2591560. [PMID: 30911422 DOI: 10.1155/2019/2591560] [Reference Citation Analysis]
21 Soriano Rios A, Paredes H, Hernández-calleros J, Uscanga-domínguez L, Peláez-luna M. Retroperitoneal fibrosis. Steroid treatment response seems to depend on its association to IgG4 related disease. Medical Hypotheses 2019;122:120-3. [DOI: 10.1016/j.mehy.2018.11.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
22 Mzabi A, Kéchrid N, Alaya Z, Rezgui A, Ben Fredj F, Bouajina E, Laouani C. [Retroperitoneal fibrosis in adults: Diagnostic approach based on a retrospective multicenter study on 32 cases]. Prog Urol 2019;29:76-85. [PMID: 30579757 DOI: 10.1016/j.purol.2018.10.006] [Reference Citation Analysis]
23 Adnan S, Bouraoui A, Mehta S, Banerjee S, Jain S, Dasgupta B. Retroperitoneal fibrosis; a single-centre case experience with literature review. Rheumatol Adv Pract 2019;3:rky050. [PMID: 31431986 DOI: 10.1093/rap/rky050] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
24 Palmisano A, Maritati F, Vaglio A. Chronic Periaortitis: an Update. Curr Rheumatol Rep 2018;20. [DOI: 10.1007/s11926-018-0789-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
25 Zhao J, Li J, Zhang Z. Long-term outcomes and predictors of a large cohort of idiopathic retroperitoneal fibrosis patients: a retrospective study. Scand J Rheumatol 2019;48:239-45. [PMID: 30270709 DOI: 10.1080/03009742.2018.1497700] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
26 Cohan RH, Shampain KL, Francis IR, Davenport MS, Stuart Wolf J, Marder W, Swartz RD. Imaging appearance of fibrosing diseases of the retroperitoneum: can a definitive diagnosis be made? Abdom Radiol (NY) 2018;43:1204-14. [PMID: 28849414 DOI: 10.1007/s00261-017-1282-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
27 Simopoulou T, Klimopoulos S, Sampaziotis D, Tzortziotis A, Bogdanos D, Sakkas LI. Inferior vena cava thrombosis as the initial presentation of IgG4-related retroperitoneal fibrosis: Case report and literature review. Journal of Scleroderma and Related Disorders 2018;3:NP1-6. [DOI: 10.1177/2397198318764793] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
28 Zhang W, Xue F, Wang C, Shao L. Clinical features and prognostic factors of ten patients with renal failure caused by IgG4-related retroperitoneal fibrosis. Oncotarget 2018;9:2858-65. [PMID: 29416818 DOI: 10.18632/oncotarget.23103] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
29 Ravindhran B, Prakash C, Govindharaj S, Bahnou NMS, Pavithra B. An Aggressive Primary Retroperitoneal Diffuse Large B-Cell Lymphoma Mimicking a Pancreatic Neoplasm, Presenting as Duodenal Stenosis. J Clin Diagn Res 2017;11:PD09-11. [PMID: 29207777 DOI: 10.7860/JCDR/2017/27222.10611] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
30 姚吉, 占鹏程, 程伟. 泌尿系梗阻对行全胃切除术后胃癌患者的生存影响. 世界华人消化杂志 2017; 25(23): 2144-2149 [DOI: 10.11569/wcjd.v25.i23.2144] [Reference Citation Analysis]
31 Runowska M, Majewski D, Puszczewicz M. Retroperitoneal fibrosis - a report of five cases. Reumatologia 2017;55:140-4. [PMID: 28769138 DOI: 10.5114/reum.2017.68914] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
32 Jadhav KK, Kumar V, Punatar CB, Joshi VS, Sagade SN. Retroperitoneal fibrosis-clinical presentation and outcome analysis from urological perspective. Investig Clin Urol 2017;58:371-7. [PMID: 28868510 DOI: 10.4111/icu.2017.58.5.371] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
33 O'brien T, Fernando A. Contemporary role of ureterolysis in retroperitoneal fibrosis: treatment of last resort or first intent? An analysis of 50 cases. BJU Int 2017;120:556-61. [DOI: 10.1111/bju.13915] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
34 Fernando A, Pattison J, Horsfield C, D’cruz D, Cook G, O’brien T. [ 18 F]-Fluorodeoxyglucose Positron Emission Tomography in the Diagnosis, Treatment Stratification, and Monitoring of Patients with Retroperitoneal Fibrosis: A Prospective Clinical Study. European Urology 2017;71:926-33. [DOI: 10.1016/j.eururo.2016.10.046] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 4.8] [Reference Citation Analysis]
35 Zhang S, Chen M, Li CM, Song GD, Liu Y. Differentiation of Lymphoma Presenting as Retroperitoneal Mass and Retroperitoneal Fibrosis: Evaluation with Multidetector-row Computed Tomography. Chin Med J (Engl) 2017;130:691-7. [PMID: 28303852 DOI: 10.4103/0366-6999.201606] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
36 Zahran MH, Osman Y, Soltan MA, Abolazm AE, Ghazy MK, Harraz AM, Shokeir AA, Abol-enein H, Ali-el-dein B. Idiopathic retroperitoneal fibrosis: clinical features and long-term renal function outcome. Int Urol Nephrol 2017;49:1327-34. [DOI: 10.1007/s11255-017-1608-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
37 Conard J, Mancini M. Retroperitoneal Fibrosis. J Am Osteopath Assoc 2017;117:340. [PMID: 28459474 DOI: 10.7556/jaoa.2017.067] [Reference Citation Analysis]
38 Yan T, Wang Y, Liu Z, Zhang X, Wu Q, Xi M. Idiopathic retroperitoneal fibrosis causing unilateral ureteral and sigmoid colon obstruction: A case report. Medicine (Baltimore) 2017;96:e6105. [PMID: 28207528 DOI: 10.1097/MD.0000000000006105] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
39 Jakhlal N, Elghazoui A, Jabbour Y, Karmouni T, Elkhader K, Koutani A, Ibenattya A. Fibrose rétropéritonéale: revue de littérature. Can Urol Assoc J 2017;11:E26-31. [PMID: 28163809 DOI: 10.5489/cuaj.4122] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
40 Rossi GM, Rocco R, Accorsi Buttini E, Marvisi C, Vaglio A. Idiopathic retroperitoneal fibrosis and its overlap with IgG4-related disease. Intern Emerg Med 2017;12:287-99. [DOI: 10.1007/s11739-016-1599-z] [Cited by in Crossref: 40] [Cited by in F6Publishing: 33] [Article Influence: 8.0] [Reference Citation Analysis]
41 Mavrogeni S, Markousis-mavrogenis G, Kolovou G. IgG4-related cardiovascular disease. The emerging role of cardiovascular imaging. European Journal of Radiology 2017;86:169-75. [DOI: 10.1016/j.ejrad.2016.11.012] [Cited by in Crossref: 32] [Cited by in F6Publishing: 24] [Article Influence: 6.4] [Reference Citation Analysis]
42 Runowska M, Majewski D, Puszczewicz M. Retroperitoneal fibrosis - the state-of-the-art. Reumatologia 2016;54:256-63. [PMID: 27994271 DOI: 10.5114/reum.2016.63667] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
43 Vasilyev VI, Sokol EV, Kokosadze NV, Pavlovskaya AI, Komov DV, Palshina SG, Mukhortova OV, Safonova TN. [The differential diagnosis of Erdheim-Chester disease and IgG4-related diseases]. Ter Arkh 2016;88:70-6. [PMID: 27239930 DOI: 10.17116/terarkh201688570-76] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
44 Maritati F, Iannuzzella F, Pavia MP, Pasquali S, Vaglio A. Kidney involvement in medium- and large-vessel vasculitis. J Nephrol 2016;29:495-505. [PMID: 27098921 DOI: 10.1007/s40620-016-0303-8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
45 Vaglio A, Maritati F. Idiopathic Retroperitoneal Fibrosis. J Am Soc Nephrol 2016;27:1880-9. [PMID: 26860343 DOI: 10.1681/ASN.2015101110] [Cited by in Crossref: 59] [Cited by in F6Publishing: 63] [Article Influence: 9.8] [Reference Citation Analysis]
46 Yachoui R, Sehgal R, Carmichael B. Idiopathic retroperitoneal fibrosis: clinicopathologic features and outcome analysis. Clin Rheumatol 2016;35:401-7. [PMID: 26208444 DOI: 10.1007/s10067-015-3022-y] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
47 Cortazar FB, Stone JH. IgG4-related disease and the kidney. Nat Rev Nephrol 2015;11:599-609. [DOI: 10.1038/nrneph.2015.95] [Cited by in Crossref: 49] [Cited by in F6Publishing: 44] [Article Influence: 7.0] [Reference Citation Analysis]
48 Cristian S, Cristian M, Cristian P, Constantin G, Savu C, Huri E, Sinescu I. Management of idiopathic retroperitoneal fibrosis from the urologist's perspective. Ther Adv Urol 2015;7:85-99. [PMID: 25829952 DOI: 10.1177/1756287214565637] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
49 Swartz RD. Retroperitoneal Fibrosis and Asbestosis—A Plausible Association? American Journal of Kidney Diseases 2015;65:378-80. [DOI: 10.1053/j.ajkd.2014.09.009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
50 Cives M, Simone V, Rizzo FM, Dicuonzo F, Cristallo Lacalamita M, Ingravallo G, Silvestris F, Dammacco F. Erdheim-Chester disease: a systematic review. Crit Rev Oncol Hematol 2015;95:1-11. [PMID: 25744785 DOI: 10.1016/j.critrevonc.2015.02.004] [Cited by in Crossref: 107] [Cited by in F6Publishing: 76] [Article Influence: 15.3] [Reference Citation Analysis]
51 Sokol EV, Vasilyev VI, Kovrigina AM, Safonova TN, Nasonov EL. [IgG4-related disease and clonal B-cell lymphoid proliferation: Description of two clinical cases and a review of literature]. Ter Arkh 2015;87:77-84. [PMID: 26978423 DOI: 10.17116/terarkh2015871277-84] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
52 Tzou M, Gazeley DJ, Mason PJ. Retroperitoneal fibrosis. Vasc Med 2014;19:407-14. [PMID: 25161213 DOI: 10.1177/1358863X14546160] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 1.4] [Reference Citation Analysis]
53 Alvarez Argote J, Bauer FA, Posteraro AF 3rd, Dasanu CA. Retroperitoneal fibrosis due to B-cell non-Hodgkin lymphoma: Responding to rituximab! J Oncol Pharm Pract 2016;22:179-85. [PMID: 25013186 DOI: 10.1177/1078155214543279] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
54 Fernández-codina A, Martínez-valle F, Castro-marrero J, De Torres I, Vilardell-tarrés M, Ordi-ros J. Idiopathic retroperitoneal fibrosis: IgG4 infiltration in a cohort of Spanish patients. Rheumatol Int 2014;34:1263-5. [DOI: 10.1007/s00296-013-2936-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
55 Bourdoumis A, Kachrilas S, Kapoor S, Zaman F, Papadopoulos G, Buchholz N, Masood J. The Use of a Thermoexpandable Metal Alloy Stent in the Minimally Invasive Management of Retroperitoneal Fibrosis: A Single Center Experience From the United Kingdom. Journal of Endourology 2014;28:96-9. [DOI: 10.1089/end.2013.0332] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
56 Gallais Sérézal I, Le Jeune S, Belenfant X, Bakir R, Fain O, Mekinian A, Gambier N, Mouthon L, Steichen O, Blanche P, Mourad JJ, Dhôte R. [Idiopathic retroperitoneal fibrosis: a multicentric retrospective study of 30 French cases and follow-up of the renal function]. Rev Med Interne 2014;35:570-6. [PMID: 24314845 DOI: 10.1016/j.revmed.2013.11.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
57 Lugosi M, Sacré K, Lidove O, Chauveheid M, Brihaye B, Laissy J, Chauchard M, Papo T. Fibrose(s) rétropéritonéale(s) : stratégie diagnostique, pathologies associées et suivi à long terme d’une cohorte française. La Revue de Médecine Interne 2013;34:591-9. [DOI: 10.1016/j.revmed.2013.02.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
58 Tejón Menéndez P, Alonso S, Alperi M, Ballina J. Paniculitis mesentérica en un paciente con espondilitis anquilosante. Reumatología Clínica 2013;9:197. [DOI: 10.1016/j.reuma.2012.10.014] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
59 Pipitone N, Vaglio A, Salvarani C. Retroperitoneal fibrosis. Best Pract Res Clin Rheumatol 2012;26:439-48. [PMID: 23040359 DOI: 10.1016/j.berh.2012.07.004] [Cited by in Crossref: 42] [Cited by in F6Publishing: 24] [Article Influence: 4.7] [Reference Citation Analysis]
60 Tejón Menéndez P, Alonso S, Alperi M, Ballina J. Mesenteric panniculitis in a patient with ankylosing spondylitis. Reumatol Clin. 2013;9:197. [PMID: 23523461 DOI: 10.1016/j.reumae.2013.04.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
61 Fernández-codina A, Martínez-valle F, Castro-marrero J, Detorres I, Vilardell-tarrés M, Ordi-ros J. Idiopathic retroperitoneal fibrosis: a clinicopathological study in 24 Spanish cases. Clin Rheumatol 2013;32:889-93. [DOI: 10.1007/s10067-013-2225-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
62 Ribichini F, Tomai F, Pesarini G, Zivelonghi C, Rognoni A, De Luca G, Boccuzzi G, Presbitero P, Ferrero V, Ghini AS, Marino P, Vassanelli C, Ribichini F, Ferrero V, Pesarini G, Dal Dosso S, Vassanelli C, Tanguay J, Tomai F, Presbitero P, Minelli M, Marino P, Anselmi M, Abukarsh R, Cima A, Ferrara A, Ferrero V, Menegatti G, Molinari G, Pesarini G, Ribichini F, Sparta D, Altamura L, Aurigemma C, Beraldi M, Corvo P, De Luca L, De Persio G, Ghini AS, Pastori F, Pellanda J, Petrolini A, Skossyreva O, Tomai. Ospedale F, Ospedale S, Bosco G, Boccuzzi G, Colangelo S, Garbo R, Minelli M, Noussan P, Belli G, Presbitero P, Rossi M, Soregaroli D, Zavalloni D, De Luca G, Franchi E, Leverone M, Rognoni A, Brunelleschi S, Feola M, Trinita OS, Menegatti G, Noussan P, Giovanni OS, Zanolla L, Magnani C; the CEREA-DES Investigators. Long-term clinical follow-up of the multicentre, randomized study to test immunosuppressive therapy with oral prednisone for the prevention of restenosis after percutaneous coronary interventions: Cortisone plus BMS or DES veRsus BMS alone to EliminAte Restenosis (CEREA-DES). European Heart Journal 2013;34:1740-8. [DOI: 10.1093/eurheartj/eht079] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 2.2] [Reference Citation Analysis]
63 Caiafa RO, Vinuesa AS, Izquierdo RS, Brufau BP, Ayuso Colella JR, Molina CN. Retroperitoneal Fibrosis: Role of Imaging in Diagnosis and Follow-up. RadioGraphics 2013;33:535-52. [DOI: 10.1148/rg.332125085] [Cited by in Crossref: 58] [Cited by in F6Publishing: 50] [Article Influence: 6.4] [Reference Citation Analysis]
64 Ellimoottil C, Hart S, Mehta V, Quek ML. Localized perirenal retroperitoneal fibrosis. Urology 2013;81:e27-8. [PMID: 23497982 DOI: 10.1016/j.urology.2013.01.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
65 Fujimori N, Ito T, Igarashi H, Oono T, Nakamura T, Niina Y, Hijioka M, Lee L, Uchida M, Takayanagi R. Retroperitoneal fibrosis associated with immunoglobulin G4-related disease. World J Gastroenterol 2013; 19(1): 35-41 [PMID: 23326160 DOI: 10.3748/wjg.v19.i1.35] [Cited by in CrossRef: 40] [Cited by in F6Publishing: 28] [Article Influence: 4.4] [Reference Citation Analysis]
66 Shirani M, Davoudian A, Sharifi A. Retroperitoneal fibrosis associated with propranolol: a case report; is corticosteroid administration necessary after ureterolysis? J Renal Inj Prev 2013;2:67-9. [PMID: 25340131 DOI: 10.12861/jrip.2013.22] [Reference Citation Analysis]
67 Gómez García I, Sánchez Castaño A, Romero Molina M, Rubio Hidalgo E, García Betancourth N, Labra González R, Sampietro Crespo A, Álvarez Fernández F, Flores Herrero Á, Gómez Rodríguez A. Retroperitoneal fibrosis: single-centre experience from 1992 to 2010, current status of knowledge and review of the international literature. Scand J Urol 2013;47:370-7. [PMID: 23206245 DOI: 10.3109/00365599.2012.747564] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
68 Naderi AA, Houston BA, Sperati CJ. All wrapped up and nowhere to flow. Am J Med 2012;125:876-9. [PMID: 22682790 DOI: 10.1016/j.amjmed.2012.02.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
69 Clevenger JA, Wang M, MacLennan GT, Montironi R, Lopez-Beltran A, Cheng L. Evidence for clonal fibroblast proliferation and autoimmune process in idiopathic retroperitoneal fibrosis. Hum Pathol 2012;43:1875-80. [PMID: 22561019 DOI: 10.1016/j.humpath.2012.01.012] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
70 Ishizaka N, Sakamoto A, Imai Y, Terasaki F, Nagai R. Multifocal fibrosclerosis and IgG4-related disease involving the cardiovascular system. J Cardiol. 2012;59:132-138. [PMID: 22137380 DOI: 10.1016/j.jjcc.2011.10.005] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 2.8] [Reference Citation Analysis]
71 Bye D, Wiggins T, Pereira B, Brearley S. Retroperitoneal fibrosis misinterpreted as an abdominal aortic aneurysm on ultrasound. BMJ Case Rep 2011;2011:bcr0820114658. [PMID: 22679331 DOI: 10.1136/bcr.08.2011.4658] [Reference Citation Analysis]